BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 30636308)

  • 1. Radiotherapy and immunotherapy: a synergistic effect in cancer care.
    Turgeon GA; Weickhardt A; Azad AA; Solomon B; Siva S
    Med J Aust; 2019 Jan; 210(1):47-53. PubMed ID: 30636308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
    Esposito A; Criscitiello C; Curigliano G
    Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy and immunotherapy: a beneficial liaison?
    Weichselbaum RR; Liang H; Deng L; Fu YX
    Nat Rev Clin Oncol; 2017 Jun; 14(6):365-379. PubMed ID: 28094262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity.
    Donlon NE; Power R; Hayes C; Reynolds JV; Lysaght J
    Cancer Lett; 2021 Apr; 502():84-96. PubMed ID: 33450360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations.
    Colton M; Cheadle EJ; Honeychurch J; Illidge TM
    Radiat Oncol; 2020 Nov; 15(1):254. PubMed ID: 33148287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy and Immunotherapy: Improving Cancer Treatment through Synergy.
    Reynders K; De Ruysscher D
    Prog Tumor Res; 2015; 42():67-78. PubMed ID: 26383848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining immunotherapy and radiotherapy in lung cancer.
    Bhalla N; Brooker R; Brada M
    J Thorac Dis; 2018 May; 10(Suppl 13):S1447-S1460. PubMed ID: 29951296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral immunotherapy: using the tumor as the remedy.
    Marabelle A; Tselikas L; de Baere T; Houot R
    Ann Oncol; 2017 Dec; 28(suppl_12):xii33-xii43. PubMed ID: 29253115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetics and immunotherapy: The current state of play.
    Dunn J; Rao S
    Mol Immunol; 2017 Jul; 87():227-239. PubMed ID: 28511092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of radiotherapy in the age of immunotherapy.
    Sato H; Demaria S; Ohno T
    Jpn J Clin Oncol; 2021 Apr; 51(4):513-522. PubMed ID: 33561212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?
    de Charette M; Marabelle A; Houot R
    Eur J Cancer; 2016 Nov; 68():134-147. PubMed ID: 27755997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining antibody-drug conjugates and immune-mediated cancer therapy: What to expect?
    Gerber HP; Sapra P; Loganzo F; May C
    Biochem Pharmacol; 2016 Feb; 102():1-6. PubMed ID: 26686577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree.
    Sheen MR; Fiering S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1524. PubMed ID: 29667346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunotherapy and radiotherapy].
    Bockel S; Antoni D; Deutsch É; Mornex F
    Cancer Radiother; 2017 May; 21(3):244-255. PubMed ID: 28522277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of radiotherapy and immune checkpoint inhibitors.
    Pilones KA; Vanpouille-Box C; Demaria S
    Semin Radiat Oncol; 2015 Jan; 25(1):28-33. PubMed ID: 25481263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immuno-oncology: Allying forces of radio- and immuno-therapy to enhance cancer cell killing.
    Bernier J
    Crit Rev Oncol Hematol; 2016 Dec; 108():97-108. PubMed ID: 27931845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?
    Madden DL
    Curr Oncol Rep; 2018 Feb; 20(1):8. PubMed ID: 29411148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?
    Lee L; Matulonis U
    Gynecol Oncol; 2019 Jul; 154(1):236-245. PubMed ID: 30995960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-195/-16 Family Enhances Radiotherapy via T Cell Activation in the Tumor Microenvironment by Blocking the PD-L1 Immune Checkpoint.
    Tao Z; Xu S; Ruan H; Wang T; Song W; Qian L; Chen K
    Cell Physiol Biochem; 2018; 48(2):801-814. PubMed ID: 30032144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic ablative radiotherapy and immunotherapy combinations: turning the future into systemic therapy?
    Walshaw RC; Honeychurch J; Illidge TM
    Br J Radiol; 2016 Oct; 89(1066):20160472. PubMed ID: 27556933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.